Table 1

Baseline characteristics

PrasugrelTicagrelorP value
Patients, n207335 917
Demographics
Age, mean±SD62.2 (10.2)66.5 (11.2)<0.001
 ≥71 years434 (25.6)13 511 (37.6)<0.001
 ≥75 years156 (7.5)8069 (22.5)<0.001
Weight, kg, mean±SD85.5 (15.8)82.4 (15.8)<0.001
Weight ≤60 kg78 (3.9)2513 (7.1)<0.001
Female sex435 (21.0)9657 (26.9)<0.001
Medical history
Smoking<0.001
 Never smoker644 (32.1)13 150 (37.6)
 Previous smoker715 (35.6)12 464 (35.7)
 Current smoker648 (32.3)9338 (26.7)
Previous MI488 (23.5)6524 (18.2)<0.001
History of diabetes mellitus500 (24.2)7674 (21.4)0.003
History of hypertension1006 (48.8)18 544 (51.8)0.008
History of hyperlipidaemia616 (29.9)8858 (25.0)<0.001
Previous PCI457 (22.1)5363 (15.0)<0.001
Previous CABG114 (5.5)2002 (5.6)0.885
Previous stroke90 (4.3)2139 (6.0)0.002
History of CHF88 (4.5)1348 (3.8)0.136
History of renal failure, on dialysis11 (0.5)119 (0.3)0.131
History of COPD88 (4.2)1914 (5.3)0.032
History of PAD71 (3.4)1184 (3.3)0.750
History of dementia2 (0.1)86 (0.2)0.188
History of cancer*28 (1.4)750 (2.1)0.021
Previous bleeding63 (3.0)1321 (3.7)0.131
  • Results are presented as numbers and percentages unless otherwise indicated.

  • *Any cancer diagnosis in the last 3 years.

  • CABG, coronary artery bypass grafting; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; PAD, peripheral artery disease; PCI, percutaneous coronary intervention.